Beacon Biosignals Funding: $132M Raised, Series B (2025)

Beacon Biosignals funding overview

Beacon Biosignals is a Healthtech company based in United States. Beacon Biosignals has raised $132M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2025. The round record for Beacon Biosignals runs through 2025; nothing later has been disclosed. Investors on record include Innoviva Specialty Therapeutics, GV (Google Ventures), General Catalyst, S32, Catalio Capital Management, Casdin Capital and 8 others. 14 distinct backers are named across the disclosed rounds.

Beacon Biosignals at a glance

Total raised: $132M
Latest round: Series B
Latest round date: November 2025
Industry: Healthtech
Headquarters: United States
Notable investors: Innoviva Specialty Therapeutics, GV (Google Ventures), General Catalyst, S32, Catalio Capital Management, Casdin Capital, JSL Health Capital, Samsung Next

Frequently asked about Beacon Biosignals funding

How much has Beacon Biosignals raised?: Beacon Biosignals has raised $132M in total disclosed funding across the rounds on record.
Who has invested in Beacon Biosignals?: Innoviva Specialty Therapeutics, GV (Google Ventures), General Catalyst, S32, Catalio Capital Management, Casdin Capital are named among the investors backing Beacon Biosignals.
What was the latest Beacon Biosignals funding round?: The most recent disclosed round is a Series B, announced in November 2025.
Where is Beacon Biosignals based?: Beacon Biosignals is based in United States.
What sector does Beacon Biosignals operate in?: Beacon Biosignals is tracked under Healthtech from United States, with $132M in disclosed funding.
When did Beacon Biosignals last raise?: The last disclosed Beacon Biosignals round closed in November 2025 at Series B.

Every Beacon Biosignals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in United States at a similar stage.

Beacon Biosignals Funding: $132M Raised, Series B (2025)

Beacon Biosignals funding overview

Beacon Biosignals at a glance

Frequently asked about Beacon Biosignals funding

Beacon Biosignals founders (1)

Companies related to Beacon Biosignals (36)

Browse related funding lists (8)